Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Michael Grier

Pain Medicine Anderson, SC Medical Doctor

NPI 1700833878 CMS profile 77529

100 Health Way Suite 1260, Piedmont Comprehensive Pain Management Group, Anderson, SC 29621

Open in the dashboard

General payments

$3,959

154 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Michael Grier of Anderson, SC is reported in the CMS Open Payments database as having received $3,959 across 154 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 60th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $345 8
2022 General $1,167 39
2021 General $533 24
2020 General $372 17
2019 General $1,541 66

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Grier
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Michael Grier were reported at $0. Among 757 Pain Medicine profiles paid that year, the median was $470 and the middle half received between $146 and $1,462.

Show as a table
Year Michael Grier Pain Medicine median Middle half National median
2019 $1,541 $506 $144–$1,566 $163
2020 $372 $315 $96–$934 $114
2021 $533 $452 $134–$1,237 $132
2022 $1,167 $475 $124–$1,407 $149
2023 $345 $480 $136–$1,384 $160
2024 $0 $521 $164–$1,511 $164
2025 $0 $470 $146–$1,462 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Boston Scientific Corporation $1,869 55 payments
  2. Collegium Pharmaceutical, Inc. $422 12 payments
  3. Forte Bio-Pharma LLC $232 5 payments
  4. Flexion Therapeutics, Inc. $218 15 payments
  5. Scilex Pharmaceuticals Inc. $213 11 payments
  6. AbbVie, Inc. $99 6 payments
  7. Amgen Inc. $83 3 payments
  8. Lundbeck LLC $83 4 payments
  9. Painteq LLC $76 1 payment
  10. GRT US Holding, Inc. $65 3 payments
  11. Other $599 39 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Food and Beverage $3,959 154 payments
Products named General payments · program years 2019–2023
  1. WaveWriter Alpha Prime 16 $555 8 payments
  2. GENERAL PAIN MANAGEMENT $494 19 payments
  3. SPECTRA WAVEWRITER $325 10 payments
  4. Zilretta $218 15 payments
  5. PROLATE Pain $209 4 payments
  6. PROLATE Pain $209 4 payments
  7. PROLATE Pain $209 4 payments
  8. PROLATE Pain $209 4 payments
  9. NALOCET $209 4 payments
  10. GENERAL - PAIN MANAGEMENT $183 6 payments
  11. Other $1,954 93 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

154 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record